| 000 | 01865 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250518041337.0 | ||
| 264 | 0 | _c20190826 | |
| 008 | 201908s 0 0 eng d | ||
| 022 | _a1095-6859 | ||
| 024 | 7 |
_a10.1016/j.ygyno.2019.05.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChapman, Bhavana V | |
| 245 | 0 | 0 |
_aAdjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer. _h[electronic resource] |
| 260 |
_bGynecologic oncology _c07 2019 |
||
| 300 |
_a22-28 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Endometrioid _xpathology |
| 650 | 0 | 4 | _aChemoradiotherapy, Adjuvant |
| 650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
| 650 | 0 | 4 |
_aEndometrial Neoplasms _xpathology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLymphatic Metastasis |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSwanick, Cameron W | |
| 700 | 1 | _aNing, Matthew S | |
| 700 | 1 | _aAllen, Pamela K | |
| 700 | 1 | _aSoliman, Pamela T | |
| 700 | 1 | _aWestin, Shannon N | |
| 700 | 1 | _aPardeshi, Vishakha | |
| 700 | 1 | _aBroaddus, Russell R | |
| 700 | 1 | _aLu, Karen H | |
| 700 | 1 | _aJhingran, Anuja | |
| 700 | 1 | _aEifel, Patricia J | |
| 700 | 1 | _aKlopp, Ann H | |
| 773 | 0 |
_tGynecologic oncology _gvol. 154 _gno. 1 _gp. 22-28 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ygyno.2019.05.002 _zAvailable from publisher's website |
| 999 |
_c29710795 _d29710795 |
||